logo

For the Inventor, By the Inventor

East Brunswick, NJ, United States of America

Savient Pharmaceuticals, Inc.

Calculating rank
USPTO Granted Patents = 13

% Expired Patents = 15.4

Trademarks = 3

Forward Citations = 193

Loading Chart...
Loading Chart...

11 inventors (with patents filed for the assignee):

goldMedal Simona Mendelovitz (9 out of 17 patents)

silverMedal Jacob R Hartman (9 out of 32 patents)

bronzeMedal Don Fishbein (3 out of 4 patents)

4.  Michael S Hershfield (1 out of 13 patents)

5.  Claudia D Rehrig (1 out of 1 patent)

6.  William Huang (1 out of 1 patent)

7.  Rachel Guy (1 out of 9 patents)

8.  Avigdor Levanon (1 out of 28 patents)

9.  Tikva Vogel (1 out of 15 patents)

10.  Amos Panet (1 out of 8 patents)

11.  Moshe M Werber (1 out of 13 patents)


13 patents:

1. 8541205 - Variant forms of urate oxidase and use thereof (2013-09-24),
2. 8465735 - Variant form of urate oxidase and use thereof (2013-06-18),
3. 8293228 - Variant form of urate oxidase and use thereof (2012-10-23),
4. 8188224 - Variant forms of urate oxidase and use thereof (2012-05-29),
5. 8178334 - Variant form of urate oxidase and use thereof (2012-05-15),
6. 8148123 - Methods for lowering elevated uric acid levels using intravenous injections of PEG-uricase (2012-04-03),
7. 8053425 - Use of oxandrolone in the treatment of burns and other wounds (2011-11-08),
8. 8034594 - Variant form of urate oxidase and use thereof (2011-10-11),
9. 8026274 - Use of oxandrolone in the treatment of burns and other wounds (2011-09-27),
10. 7964381 - Variant form of urate oxidase and use thereof (2011-06-21),
11. 7811800 - Variant form of urate oxidase and use thereof (2010-10-12),
12. 7087722 - Fibrin binding domain polypeptides and uses and methods of producing same (2006-08-08),
13. 6828313 - Use of oxandrolone in the treatment of burns and other wounds (2004-12-07),
Company Overview
Savient Pharmaceuticals, Inc. is a biopharmaceutical company based in East Brunswick, NJ, focused on developing innovative therapies for rare diseases. The company specializes in the research and commercialization of treatments that address unmet medical needs, particularly in the field of metabolic disorders. Savient is dedicated to advancing its proprietary technologies to improve patient outcomes and enhance the quality of life for individuals affected by these conditions.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 27 2026

13 Patents

#4 in East Brunswick, NJ

#896 in New Jersey

#23,863 in US

#45,104 in the World

East Brunswick, NJ (US)
East Brunswick, NJ, United States of America

Savient Pharmaceuticals, Inc.

Forward Citations = 193

11 inventors:

goldMedal Simona Mendelovitz (9 out of 17 patents)

silverMedal Jacob R Hartman (9 out of 32 patents)

bronzeMedal Don Fishbein (3 out of 4 patents)

4.  Michael S Hershfield (1 out of 13 patents)

5.  Claudia D Rehrig (1 out of 1 patent)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Savient Pharmaceuticals, Inc.. Retrieved from https://idiyas.com/company/savient-pharmaceuticals

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…